Comparison of soymilk and probiotic soymilk effects on serum high-density lipoprotein cholesterol and low-density lipoprotein cholesterol in diabetic wistar rats

ARYA Atherosclerosis

Volumn 11, Issue , 2015, Pages

  Babashahi, Mina ^a   Mirlohi, Maryam ^b   Ghiasvand, Reza ^b   Azadbakht, Leila ^b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

High density lipoprotein cholesterol; Lactobacillus; Low density lipoprotein cholesterol; Probiotic; Soy milk

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLONY FORMING UNIT; COMPARATIVE STUDY; DIABETES MELLITUS; FERMENTATION; GROWTH CURVE; LACTOBACILLUS PLANTARUM; MALE; NONHUMAN; NUTRIENT CONTENT; PH; PROBIOTIC SOYMILK; RAT; SOYBEAN MILK;

EID: 84928642278     PISSN: 17353955     EISSN: 22516638     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2014; 37(1): 81-90.
2. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014; 103(2): 137-49.
3. Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011; 94(3): 311-21.
4. Shaw J., Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87(1): 4-14.
5. Zhang P, Zhang X, Brown J, Vistisen D, Sicree R, Shaw J, et al. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87(3): 293-301.
6. Venter CS. Health benefits of soy beans and soy products: a review. Journal of Family Ecologyand Consumer Sciences 1999; 27(1): 24-33.
7. Liu ZM, Chen YM, Ho SC. Effects of soy intake on glycemic control: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2011; 93(5): 1092-101.
8. Ju HE, Han JS. Hypoglycemic effect of fermented soymilk added with bokbunja (Rubus coreanus Miquel) in diabetic mice. Food Science and Biotechnology 2010; 19(4): 1041-6.
9. Ribnicky DM, Roopchand DE, Poulev A, Kuhn P, Oren A, Cefalu WT, et al. Artemisia dracunculus L. polyphenols complexed to soy protein show enhanced bioavailability and hypoglycemic activity in C57BL/6 mice. Nutrition 2014; 30(7-8 Suppl): S4-10.
10. Zhan S, Ho SC. Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr 2005; 81(2): 397-408.
11. Li H, Yan L, Wang J, Zhang Q, Zhou Q, Sun T, et al. Fermentation characteristics of six probiotic strains in soymilk. Annals of Microbiology 2012; 62(4): 1473-83.
12. Kim Y, Yoon S, Lee SB, Han HW, Oh H, Lee WJ, et al. Fermentation of soy milk via Lactobacillus plantarum improves dysregulated lipid metabolism in rats on a high cholesterol diet. PLoS One 2014; 9(2): e88231.
13. Marazza JA, LeBlanc JG, de Giori GS, Garro MS. Soymilk fermented with Lactobacillus rhamnosus CRL981 ameliorates hyperglycemia, lipid profiles and increases antioxidant enzyme activities in diabetic mice. Journal of Functional Foods 2013; 5(4): 1848-53.
14. Giacco R, De Giulio B, Vitale M, Cozzolino R. Functional Foods: Can Food Technology Help in the Prevention and Treatment of Diabetes? Food and Nutrition Sciences 2013; 4: 827-37.
15. Ademiluyi AO, Oboh G, Boligon AA, Athayde ML. Effect of fermented soybean condiment supplemented diet on α-amylase and α-glucosidase activities in Streptozotocin-induced diabetic rats. Journal of Functional Foods 2014; 9: 1-9.
16. Bomba A, Brandeburová A, Ricanyová J, Strojný L, Chmelárová A, Szabadosová V. The role of probiotics and natural bioactive compounds in modulation of the common molecular pathways in pathogenesis of atherosclerosis and cancer. Biologia 2012; 67(1): 1-13.
17. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014; 11(8): 506-14.
18. Mirlohi M, Soleimanian-Zad S, Dokhani S, Sheikh Zeinodin M, Abghary A. Investigation of Acid and Bile Tolerance of Native Lactobacilli Isolated from Fecal Samples and Commercial Probiotics by Growth and Survival Studies. Iranian Journal of Biotechnology 2009; 7(4): 233-40.
19. Fazeli H, Moshtaghian J, Mirlohi M, Shirzadi M. Reduction in serum lipid parameters by incorporation of a native strain of Lactobacillus Plantarum A7 in Mice. Iran J Diabetes Lipid Disord 2010; 9: 1-7. [In Persian].
20. Mirlohi M, Soleimanian-Zad S, Dokhani Sh, Sheikh-Zeinodin M. Microbial and physiochemical changes in yoghurts containing different Lactobacillus delbrueckii subsp. bulgaricus strains in association with Lactobacillus plantarum as an adjunct culture. International Journal of Dairy Technology 2014; 67(2): 246-54.
21. Tahara A, Matsuyama-Yokono A, Nakano R, Someya Y, Shibasaki M. Hypoglycaemic effects of antidiabetic drugs in streptozotocin-nicotinamideinduced mildly diabetic and streptozotocin-induced severely diabetic rats. Basic Clin Pharmacol Toxicol 2008; 103(6): 560-8.
22. Chen T, Kagan L, Mager DE. Population pharmacodynamic modeling of exenatide after 2week treatment in STZ/NA diabetic rats. J Pharm Sci 2013; 102(10): 3844-51.
23. Kim JH, Lee DE, Choi SH, Cha JH, Bak EJ, Yoo YJ. Diabetic characteristics and alveolar bone loss in streptozotocin- and streptozotocin-nicotinamidetreated rats with periodontitis. J Periodontal Res 2014; 49(6): 792-800.
24. Petchi RR, Vijaya C, Parasuraman S. Antidiabetic activity of polyherbal formulation in streptozotocin - nicotinamide induced diabetic wistar rats. J Tradit Complement Med 2014; 4(2): 108-17.
25. Minaiyan M, Ghannadi A, Movahedian A, Ramezanlou P, Osooli FS. Effect of the hydroalcoholic extract and juice of Prunus divaricata fruit on blood glucose and serum lipids of normal and streptozotocin-induced diabetic rats. Res Pharm Sci 2014; 9(6): 421-9.
26. Lu MP, Wang R, Song X, Chibbar R, Wang X, Wu L, et al. Dietary soy isoflavones increase insulin secretion and prevent the development of diabetic cataracts in streptozotocin-induced diabetic rats. Nutr Res 2008; 28(7): 464-71.
27. Nordentoft I, Jeppesen PB, Hong J, Abudula R, Hermansen K. Increased insulin sensitivity and changes in the expression profile of key insulin regulatory genes and beta cell transcription factors in diabetic KKAy-mice after feeding with a soy bean protein rich diet high in isoflavone content. J Agric Food Chem 2008; 56(12): 4377-85.
28. Noriega-Lopez L, Tovar AR, Gonzalez-Granillo M, Hernandez-Pando R, Escalante B, SantillanDoherty P, et al. Pancreatic insulin secretion in rats fed a soy protein high fat diet depends on the interaction between the amino acid pattern and isoflavones. J Biol Chem 2007; 282(28): 20657-66.
29. Mezei O, Banz WJ, Steger RW, Peluso MR, Winters TA, Shay N. Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells. J Nutr 2003; 133(5): 1238-43.
30. Ricketts ML, Moore DD, Banz WJ, Mezei O, Shay NF. Molecular mechanisms of action of the soy isoflavones includes activation of promiscuous nuclear receptors. A review. J Nutr Biochem 2005; 16(6): 321-30.
31. Potter SM. Overview of proposed mechanisms for the hypocholesterolemic effect of soy. J Nutr 1995; 125(3 Suppl): 606S-11S.
32. Torres N, Torre-Villalvazo I, Tovar AR. Regulation of lipid metabolism by soy protein and its implication in diseases mediated by lipid disorders. J Nutr Biochem 2006; 17(6): 365-73.
33. Veloso RV, Latorraca MQ, Arantes VC, Reis MA, Ferreira F, Boschero AC, et al. Soybean diet improves insulin secretion through activation of cAMP/PKA pathway in rats. J Nutr Biochem 2008; 19(11): 778-84.
34. Cho SJ, Juillerat MA, Lee CH. Cholesterol lowering mechanism of soybean protein hydrolysate. J Agric Food Chem 2007; 55(26): 10599-604.
35. Rossi EA, Vendramini RC, Carlos IZ, Ueiji IS, Squinzari MM, Silva Junior SI, et al. Effects of a novel fermented soy product on the serum lipids of hypercholesterolemic rabbits. Arq Bras Cardiol 2000; 74(3): 209-16.
36. Kwon DY, Daily JW, III, Kim HJ, Park S. Antidiabetic effects of fermented soybean products on type 2 diabetes. Nutr Res 2010; 30(1): 1-13.
37. Wang JC, Zhang WY, Zhong Z, Wei AB, Bao QH, Zhang Y, et al. Transcriptome analysis of probiotic Lactobacillus casei Zhang during fermentation in soymilk. J Ind Microbiol Biotechnol 2012; 39(1): 191-206.
38. Kawakami Y, Tsurugasaki W, Nakamura S, Osada K. Comparison of regulative functions between dietary soy isoflavones aglycone and glucoside on lipid metabolism in rats fed cholesterol. J Nutr Biochem 2005; 16(4): 205-12.
39. Xie N, Cui Y, Yin YN, Zhao X, Yang JW, Wang ZG, et al. Effects of two Lactobacillus strains on lipid metabolism and intestinal microflora in rats fed a high-cholesterol diet. BMC Complement Altern Med 2011; 11: 53.
40. Wang Z, Bao Y, Zhang Y, Zhang J, Yao G, Wang S, et al. Effect of Soymilk Fermented with Lactobacillus plantarum P-8 on Lipid Metabolism and Fecal Microbiota in Experimental Hyperlipidemic Rats. Food Biophysics 2012; 8(1): 43-9.